ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 76 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $19,000 | -75.0% | 14,740 | -55.4% | 0.00% | – |
| Q3 2021 | $76,000 | -13.6% | 33,030 | +65.2% | 0.00% | – |
| Q2 2021 | $88,000 | -82.3% | 19,998 | -70.8% | 0.00% | -100.0% |
| Q1 2021 | $497,000 | +41.6% | 68,472 | -15.7% | 0.00% | 0.0% |
| Q4 2020 | $351,000 | +127.9% | 81,183 | +216.2% | 0.00% | +50.0% |
| Q2 2020 | $154,000 | +12.4% | 25,673 | +40.7% | 0.00% | -50.0% |
| Q1 2020 | $137,000 | -13.8% | 18,244 | +57.6% | 0.00% | +300.0% |
| Q4 2019 | $159,000 | – | 11,578 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |